StockWatch
·
Specialty Chemicals
Board Meeting4 Aug 2026, 02:38 pm

Alkyl Amines Board Approves Unaudited Q1 FY27 Results & Director Re-designations

AI Summary

Alkyl Amines Chemicals Ltd announced that its Board of Directors, in a meeting held on August 4, 2026, approved the unaudited financial results for the quarter ended June 30, 2026. The board also approved several key management re-designations, effective October 1, 2026, including Mr. Yogesh M. Kothari as Executive Chairman, and Mr. Kirat M. Patel and Mr. Suneet Y. Kothari as Joint Managing Directors. Mr. Rakesh Goyal was re-designated as Executive Director - Operations. Additionally, the board approved the payment of commission to Non-Executive Directors, not exceeding 1% of net profits for a further five years from FY2027-28. The trading window will open on August 7, 2026.

Key Highlights

  • Unaudited financial results for Q1 FY27 approved.
  • Key director re-designations approved, effective Oct 1, 2026.
  • Commission payment to Non-Executive Directors approved.
  • Trading window to open on August 7, 2026.